Here's another lot feeding off OUR NHS.

'Established in 1989 as a spin out from Queen Mary University, London, hVIVO, part of Open Orphan plc is a trusted partner and industry-leading clinical development services business pioneering human disease models based upon viral challenge. Using human challenge studies to establish early proof-of-concept, hVIVO’s clinical trial platform can accelerate drug and vaccine development in respiratory and infectious disease.'

_______
Piling in and following the money.

https://otp.tools.investis.com/clients/uk/open_orphan/rns/regulatory-story.aspx?cid=2484&newsid=1430867

Sounds like the Wild West out there.